Global X Genomics & Biotechnology ETF
GNOM
GNOM
63 hedge funds and large institutions have $35M invested in Global X Genomics & Biotechnology ETF in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.24M | |
| 2 | +$1.1M | |
| 3 | +$936K | |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
+$558K |
| 5 |
Two Sigma Investments
New York
|
+$551K |
Top Sellers
| 1 | -$590K | |
| 2 | -$585K | |
| 3 | -$360K | |
| 4 |
Jane Street
New York
|
-$186K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$180K |